Skip to main content

Adverum Biotechnologies, Inc.

ADVMDelisted Dec 9, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501756

Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.

Q3 2025 vs. Q2 2025

How the institutions holding Adverum Biotechnologies, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of ADVM: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders5950−9
Shares14.0M14.1M+63.5K (+0.5%)
Value$30.1M$63.8M+$33.6M (+111.6%)

New holders (6)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to ADVM in Q3 2025
InstitutionSharesValue% of portfolio
JustInvest LLC12,805$58.0K0.00%
UMA Financial Services, Inc.217$9840.00%
JPMorgan Chase & Co182$8240.00%
Barclays PLC21$960.00%
SRS Capital Advisors, Inc.19$860.00%
Sound Income Strategies, LLC1$50.00%

Sold out (15)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.